Correlation Between Kyocera and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kyocera and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kyocera and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kyocera and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Kyocera and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kyocera with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kyocera and Arrowhead Pharmaceuticals.

Diversification Opportunities for Kyocera and Arrowhead Pharmaceuticals

  Correlation Coefficient

Good diversification

The 24 months correlation between Kyocera and Arrowhead is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Kyocera and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Kyocera is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kyocera are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Kyocera i.e., Kyocera and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kyocera and Arrowhead Pharmaceuticals

Assuming the 90 days horizon Kyocera is expected to under-perform the Arrowhead Pharmaceuticals. But the otc pink sheet apears to be less risky and, when comparing its historical volatility, Kyocera is 2.45 times less risky than Arrowhead Pharmaceuticals. The otc pink sheet trades about -0.09 of its potential returns per unit of risk. The Arrowhead Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  3,722  in Arrowhead Pharmaceuticals on September 3, 2022 and sell it today you would lose (329.00)  from holding Arrowhead Pharmaceuticals or give up 8.84% of portfolio value over 90 days.
Time Period24 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Kyocera  vs.  Arrowhead Pharmaceuticals

 Performance (%) 
Kyocera Performance
0 of 100
Over the last 90 days Kyocera has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2023. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Kyocera Price Channel

Arrowhead Pharmaceuticals 
Arrowhead Performance
0 of 100
Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Arrowhead Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Arrowhead Price Channel

Kyocera and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   

Pair Trading with Kyocera and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Kyocera and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kyocera position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
Kyocera vs. Apple Inc
Kyocera vs. Anheuser Busch Inbev
Kyocera vs. FT Cboe Vest
The idea behind Kyocera and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Arrowhead Pharmaceuticals vs. Anheuser Busch Inbev
Arrowhead Pharmaceuticals vs. Northwest Healthcare Properties
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk